Skip to main content
OpenTrials
Completed

NCT Number: NCT01857609

Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin

This study aims to investigate the effect of proton pump inhibitor on the pharmacokinetics and pharmacodynamics of metformin in healthy Korean men.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

20 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Seoul National University Bundang Hospital

Seoul, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy male subject aged 20 to 45 at screening
  • A body weight in the range of 50 kg (inclusive) - 100 kg (inclusive) with ideal body weight range of +- 25%
  • subjects who decide to participate voluntarily and write a informed consent form

Exclusion criteria

  • subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor
  • Subject judged not eligible for study participation by investigator.

Treatment and study plan

metformin

Drug

Other names: Diabex

Metformin and Pantoprazole

Drug

Other names: Diabex, Pantoloc

Metformin and Rabeprazole

Drug

Other names: Diabex, Pariet

Primary outcomes

  1. AUC(area under the plasma concentration-time curve)

    Time frame: Predose and 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12h postdose

    AUC(area under the plasma concentration-time curve), Cmax(maximum plasma concentration), t1/2

Secondary outcomes

  1. AUG(total area under the serum concentration-time curve for glucose)

    Time frame: predose and 15, 30, 45, 60, 90, 120, 150, 180min oral glucose tolerance test

    AUG (total area under the serum concentration-time curve for glucose) Gmax(maximum serum glucose concentration)

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

The Cross-Over Study to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Korean Men.

Acronym: MPI

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
May 20, 2013
Registry last updated
May 20, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.